<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<atom:link rel="self" href="http://media.peerviewpress.com/000136/podcast/pvi/xml/nephrology_audio.xml" type="application/rss+xml" />
		<lastBuildDate>Thu, 14 Jan 2010 11:39:14 -0500</lastBuildDate>
		<title>PeerView Nephrology CME/CNE/CPE Audio Podcast</title>
		<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
		<link>http://www.peerviewpress.com</link>
		<generator>Podcast Maker v1.3.8b - http://www.lemonzdream.com/podcastmaker</generator>
		<description><![CDATA[PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.]]></description>
		<itunes:subtitle>Thought leader perspectives on current clinical advances in medicine.</itunes:subtitle>
		<itunes:summary>PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.</itunes:summary>
		<language>en-us</language>
		<copyright>2008</copyright>
		<itunes:owner>
			<itunes:name>PeerView Press, 24 West 40th Street, Suite 950, New York, NY, 10018</itunes:name>
			<itunes:email>webmaster@peerviewpress.com</itunes:email>
		</itunes:owner>
		<image>
			<url>http://media.peerviewpress.com/000136/podcast/pvi/xml/podcast_NephrologyCME-CNE-CPE_144.jpg</url>
			<title>PeerView Nephrology CME/CNE/CPE Audio Podcast</title>
			<link>http://www.peerviewpress.com</link>
			<width>144</width>
			<height>144</height>
		</image>
		<itunes:image href="http://media.peerviewpress.com/000136/podcast/pvi/xml/podcast_NephrologyCME-CNE-CPE.jpg" />
		<category>Medicine</category>
		<itunes:category text="Science &amp; Medicine">
			<itunes:category text="Medicine" />
		</itunes:category>
		<category>Science &amp; Medicine</category>
		<itunes:category text="Science &amp; Medicine" />
		<itunes:keywords>CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Nephrology</itunes:keywords>
		<itunes:explicit>no</itunes:explicit>
		<item>
			<title>Roy D. Bloom, MD - Improving Long-Term Outcomes in Kidney Transplant Recipients: A Case-Based Approach to the Prevention and Management of Post-Transplant Morbidity</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE06135r83.mp3" length="22471185" />
			<guid>http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE06135r83.mp3</guid>
			<pubDate>Wed, 18 Nov 2009 13:49:25 -0500</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:23:22</itunes:duration>
			<itunes:keywords>kidney transplant, immunosuppression, kidney graft dysfunction, kidney graft failure</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - Improving Long-Term Outcomes in Kidney Transplant Recipients: A Case-Based Approach to the Prevention and Management of Post-Transplant Morbidity</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE06135CMEinfo.pdf" length="277954" />
			<guid>http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE06135CMEinfo.pdf</guid>
			<pubDate>Wed, 18 Nov 2009 13:49:23 -0500</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>kidney transplant, immunosuppression, kidney graft dysfunction, kidney graft failure</itunes:keywords>
		</item>
		<item>
			<title>Bernard J. Escudier, MD - Expanding Options for First-Line Treatment of Advanced Kidney Cancer: How Can We Choose the Right Treatment for the Right Patient?</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, an expert discusses the latest clinical trial data on targeted therapies for upfront treatment of metastatic RCC, assesses the clinical implications of these data, and provides recommendations for optimal integration of new agents into the current treatment paradigm for advanced RCC.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, an expert discusses the latest clinical trial data on targeted therapies for upfront treatment of metastatic RCC, assesses the clinical implications of these data, and provides recommendations for optimal integration of new agents into the current treatment paradigm for advanced RCC.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE05963s142.mp3" length="14934019" />
			<guid>http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE05963s142.mp3</guid>
			<pubDate>Wed, 12 Aug 2009 15:34:59 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:15:31</itunes:duration>
			<itunes:keywords>renal cell carcinoma, RCC, bevacizumab, sunitinib, sorafenib, interferon, VEGF, TKI, pazopanib, ASCO</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - Expanding Options for First-Line Treatment of Advanced Kidney Cancer: How Can We Choose the Right Treatment for the Right Patient?</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE05963CMEinfo.pdf" length="275707" />
			<guid>http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE05963CMEinfo.pdf</guid>
			<pubDate>Wed, 12 Aug 2009 15:34:56 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>renal cell carcinoma, RCC, bevacizumab, sunitinib, sorafenib, interferon, VEGF, TKI, pazopanib, ASCO</itunes:keywords>
		</item>
		<item>
			<title>Flavio Vincenti, MD - Improving Patient Outcomes and Survival With New Therapies in Solid Organ Transplantation</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in transplantation medicine discuss current trends in immunosuppressive therapies as well as new data presented at the 2009 American Transplant Congress.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in transplantation medicine discuss current trends in immunosuppressive therapies as well as new data presented at the 2009 American Transplant Congress.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE05995s557.mp3" length="24931187" />
			<guid>http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE05995s557.mp3</guid>
			<pubDate>Tue, 21 Jul 2009 15:43:23 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:25:56</itunes:duration>
			<itunes:keywords>organ transplants, kidney transplants, renal transplants, organ transplantation</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - Improving Patient Outcomes and Survival With New Therapies in Solid Organ Transplantation</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE05995CMEinfo.pdf" length="722890" />
			<guid>http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE05995CMEinfo.pdf</guid>
			<pubDate>Tue, 21 Jul 2009 15:43:20 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>organ transplants, kidney transplants, renal transplants, organ transplantation</itunes:keywords>
		</item>
		<item>
			<title>Robert J. Motzer, MD - Established and Emerging Therapies for Renal Cell Carcinoma: Clinical Highlights From the 2009 Meeting in Orlando</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in oncology discuss the latest data on current and emerging therapies for advanced renal cell carcinoma.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in oncology discuss the latest data on current and emerging therapies for advanced renal cell carcinoma.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://media.peerviewpress.com/000136/podcast/pvi/mp3/PA05679FCs545.mp3" length="22677927" />
			<guid>http://media.peerviewpress.com/000136/podcast/pvi/mp3/PA05679FCs545.mp3</guid>
			<pubDate>Wed, 15 Jul 2009 16:01:29 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:23:35</itunes:duration>
			<itunes:keywords>renal cell carinoma, RCC, AVOREN, CALGB, bevacizumab, interferon, TKI, pazopanib, sunitinib, AV-951</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - Established and Emerging Therapies for Renal Cell Carcinoma: Clinical Highlights From the 2009 Meeting in Orlando</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://media.peerviewpress.com/000136/podcast/pvi/pdf/PA05679FCCMEinfo.pdf" length="307881" />
			<guid>http://media.peerviewpress.com/000136/podcast/pvi/pdf/PA05679FCCMEinfo.pdf</guid>
			<pubDate>Wed, 15 Jul 2009 16:01:23 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>renal cell carinoma, RCC, AVOREN, CALGB, bevacizumab, interferon, TKI, pazopanib, sunitinib, AV-951</itunes:keywords>
		</item>
		<item>
			<title>Michael Germain, MD - State of the Art in Managing Anemia in Chronic Kidney Disease</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in management of CKD-related anemia discuss the inflammatory and other mechanisms that affect hemoglobin variability and hyporesponsiveness, as well as strategies to achieve optimal hemoglobin levels.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in management of CKD-related anemia discuss the inflammatory and other mechanisms that affect hemoglobin variability and hyporesponsiveness, as well as strategies to achieve optimal hemoglobin levels.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE05896FCe031.mp3" length="28357560" />
			<guid>http://media.peerviewpress.com/000136/podcast/pvi/mp3/PPVNE05896FCe031.mp3</guid>
			<pubDate>Fri, 26 Jun 2009 15:22:17 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:29:30</itunes:duration>
			<itunes:keywords>CKD, chronic kidney disease, anemia, CKD anemia, kidney disease</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - State of the Art in Managing Anemia in Chronic Kidney Disease</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE05896FCCMEinfo.pdf" length="708631" />
			<guid>http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE05896FCCMEinfo.pdf</guid>
			<pubDate>Fri, 26 Jun 2009 15:22:14 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>CKD, chronic kidney disease, anemia, CKD anemia, kidney disease</itunes:keywords>
		</item>
		<item>
			<title>Robert J. Motzer, MD - Clinical and Research Advances in Renal Cell Carcinoma: Updates From the 2009 Genitourinary Cancers Symposium</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts discuss recent advances in the management of kidney cancer. Latest data on new and emerging targeted treatment options will be evaluated, treatment options for RCC with sarcomatoid features will be discussed, and an evidence-based treatment algorithm for optimal integration of targeted agents into the current treatment paradigm will be provided. Additionally, research findings from studies aiming to refine the treatment of RCC will be highlighted, including those assessing the potential role of new prognostic models, clinical and genotypic variations that might influence or predict the development of toxicities associated with targeted therapies, and strategies for prevention or overcoming treatment resistance.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts discuss recent advances in the management of kidney cancer. Latest data on new and emerging targeted treatment options will be evaluated, treatment options for RCC with sarcomatoid features will be discussed, and an evidence-based treatment algorithm for optimal integration of targeted agents into the current treatment paradigm will be provided. Additionally, research findings from studies aiming to refine the treatment of RCC will be highlighted, including those assessing the potential role of new prognostic models, clinical and genotypic variations that might influence or predict the development of toxicities associated with targeted therapies, and strategies for prevention or overcoming treatment resistance.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://media.peerviewpress.com/000136/podcast/pvi/mp3/PA05349FCs515.mp3" length="19621894" />
			<guid>http://media.peerviewpress.com/000136/podcast/pvi/mp3/PA05349FCs515.mp3</guid>
			<pubDate>Mon, 11 May 2009 14:41:39 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:20:24</itunes:duration>
			<itunes:keywords>renal carcinoma, RCC, bevacizumab, everolimus, sorafenib, sunitnib, TKI, AV-951, VEGF, prognostic models</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - Clinical and Research Advances in Renal Cell Carcinoma: Updates From the 2009 Genitourinary Cancers Symposium</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://media.peerviewpress.com/000136/podcast/pvi/pdf/PA05349FCCMEinfo.pdf" length="311258" />
			<guid>http://media.peerviewpress.com/000136/podcast/pvi/pdf/PA05349FCCMEinfo.pdf</guid>
			<pubDate>Mon, 11 May 2009 14:41:37 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>renal carcinoma, RCC, bevacizumab, everolimus, sorafenib, sunitnib, TKI, AV-951, VEGF, prognostic models</itunes:keywords>
		</item>
		<item>
			<title>Craig B. Langman, MD - All-Stage Management of CKD-MBD: Insights From Renal Week 2008</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the management of CKD-MBD analyze recent data on detection and management of CKD-MBD from the 41st Annual Meeting & Scientific Exposition of the American Society of Nephrology (Renal Week 2008).]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the management of CKD-MBD analyze recent data on detection and management of CKD-MBD from the 41st Annual Meeting &amp; Scientific Exposition of the American Society of Nephrology (Renal Week 2008).</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://media.peerviewpress.com/000136/podcast/pvi/mp3/PA05477FCs539.mp3" length="44362893" />
			<guid>http://media.peerviewpress.com/000136/podcast/pvi/mp3/PA05477FCs539.mp3</guid>
			<pubDate>Wed, 01 Apr 2009 15:34:03 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:46:10</itunes:duration>
			<itunes:keywords>chronic kidney disease; mineral bone disorders; renal disease; nephrology</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - All-Stage Management of CKD-MBD: Insights From Renal Week 2008</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://media.peerviewpress.com/000136/podcast/pvi/pdf/PA05477FCCMEinfo.pdf" length="269901" />
			<guid>http://media.peerviewpress.com/000136/podcast/pvi/pdf/PA05477FCCMEinfo.pdf</guid>
			<pubDate>Wed, 01 Apr 2009 15:34:01 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>chronic kidney disease; mineral bone disorders; renal disease; nephrology</itunes:keywords>
		</item>
	</channel>
</rss>